-
The Value Flower in Bloom: Emerging Recognition of Uncaptured Benefits in NICE HTA Decisions
Sep 9, 2025, 16:22 PM -
Economic Evaluation of Atogepant vs. Placebo for the Preventive Treatment of Episodic Migraine in Taiwan
Sep 9, 2025, 16:22 PM -
A New Approach for Modeling the Complexity of the Impact of Caring Using the Family and Caregiving Effects
Sep 9, 2025, 16:22 PM -
Cost Comparison of Alternative Delivery Routes for Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RA) in the English National Health Service (NHS)
Sep 9, 2025, 16:22 PM -
The Unique Value of Detecting Preeclampsia: Comparing Health Economic Analyses of Novel Diagnostics With the ISPOR Value Flower
Sep 9, 2025, 16:22 PM -
The Next Steps Matter? New Cancer Medicines and Their Indication Extensions in Europe 2010-2020
Sep 9, 2025, 16:22 PM -
Optimizing HER2+ Breast Cancer Treatment Pathways in Italian Oncological Centers
Sep 9, 2025, 16:22 PM -
Evolution of High-Efficacy Therapies for Relapsing Multiple Sclerosis: Does Innovation Meet Patient Preferences?
Sep 9, 2025, 16:22 PM -
Validating a Medication Adherence Index in Large Urban Population
Sep 9, 2025, 16:22 PM -
Evaluating GenAI for HTA Analogue Analysis: Identifying Rare Disease Approvals With Surrogate Endpoints and Single-Arm Trials
Sep 9, 2025, 16:22 PM -
Occupational Disease Claims and Payments in Indonesia: Insights From Administrative Data 2018-2022
Sep 9, 2025, 16:22 PM -
Understanding Heterogeneity in the Classification of Locally Advanced Cancer: Analysis of Clinical Trial Records From the Past 2 Years (2023-2025)
Sep 9, 2025, 16:22 PM -
Health Technologies Using Artificial Intelligence: What Is Being Assessed in the UK by NICE?
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Ga-PSMA-11 PET/CT Imaging Followed by Lu-PSMA-617 vs. Standard of Care in Metastatic Castrate-Resistant Prostate Cancer
Sep 9, 2025, 16:22 PM -
A Cost-Effectiveness Analysis of Abrocitinib vs. Upadacitinib and Baricitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of the Prostate Health Index (PHI) Test After a Prostate-Specific Antigen (PSA) Test in UK
Sep 9, 2025, 16:22 PM -
Systematic Review of Value Assessment Frameworks for Digital Health Interventions: Toward a Multidimensional Evaluation Approach
Sep 9, 2025, 16:22 PM -
Clinical Outcomes Associated With Pembrolizumab Immunotherapy in Mesothelioma: A Systematic Review
Sep 9, 2025, 16:22 PM -
Delta Price Cost-Effectiveness Analysis of PCV21 vs. PCV20 Use in Adults Aged ≥18 Years in Austria
Sep 9, 2025, 16:22 PM -
The Mediating Role of Insomnia in the Relationship Between Disease Severity and Mental Health Quality of Life and Productivity in Atopic Dermatitis
Sep 9, 2025, 16:22 PM
